Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.20
-0.03 (-0.71%)
At close: May 30, 2025, 3:59 PM
4.00
-4.76%
After-hours: May 30, 2025, 05:42 PM EDT
-0.71% (1D)
| Bid | 3.77 |
| Market Cap | 258.34M |
| Revenue (ttm) | 159.49M |
| Net Income (ttm) | 6.15M |
| EPS (ttm) | 0.13 |
| PE Ratio (ttm) | 32.31 |
| Forward PE | -2.85 |
| Analyst | Buy |
| Ask | 4.12 |
| Volume | 376,883 |
| Avg. Volume (20D) | 701,300 |
| Open | 4.19 |
| Previous Close | 4.23 |
| Day's Range | 3.93 - 4.21 |
| 52-Week Range | 3.21 - 12.40 |
| Beta | 1.52 |
About GLUE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLUE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GLUE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+93.87%
Monte Rosa Therapeutics shares are trading higher ...
Unlock content with
Pro Subscription
2 months ago · seekingalpha.com
Monte Rosa Therapeutics, Inc. (GLUE) Q4 2024 Earnings Call TranscriptMonte Rosa Therapeutics, Inc. (NASDAQ:GLUE ) Q4 2024 Results Conference Call March 20, 2025 8:00 AM ET Company Participants Andrew Funderburk - Senior Vice President, Investor Relations and Strategic ...
